Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Presenter: A. Pieter Kappetein, Dee Dee Wang, Chad Morreale, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Aortic Valve Replacement for Severe Aortic Insufficiency in a Patient With Prior Type A Aortic Dissection Repair and Residual Type B Dissection Extending to the Infrarenal Aorta

Presenter: A. Pieter Kappetein, Dee Dee Wang, Hasan Ahmad, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Presenter: A. Pieter Kappetein, Dee Dee Wang, Arijit Chanda, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Presenter: Isaac George, Christopher U. Meduri, Marcus R. Burns

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Presenter: Michael J. Mack, Nicolo Piazza

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

Presenter: Patrick M. McCarthy, David Meerkin, Sachin Goel, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Linda D. Gillam

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Carl L. Tommaso

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease

Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD

June 21, 2018

Advertisement

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement for Severe Aortic Insufficiency in a Patient With Prior Type A Aortic Dissection Repair and Residual Type B Dissection Extending to the Infrarenal Aorta

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content